11 results on '"Kirchner, U."'
Search Results
2. Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [ 68 Ga]PSMA I&T and comparison with published data of [ 68 Ga]PSMA HBED-CC.
- Author
-
Berliner C, Tienken M, Frenzel T, Kobayashi Y, Helberg A, Kirchner U, Klutmann S, Beyersdorff D, Budäus L, Wester HJ, Mester J, and Bannas P
- Subjects
- Aged, Aged, 80 and over, Coordination Complexes pharmacology, Edetic Acid analogs & derivatives, Gallium Isotopes, Gallium Radioisotopes, Humans, Male, Middle Aged, Oligopeptides pharmacology, Prostatic Neoplasms blood, Sensitivity and Specificity, Antigens, Surface blood, Coordination Complexes pharmacokinetics, Glutamate Carboxypeptidase II blood, Oligopeptides pharmacokinetics, Organometallic Compounds, Positron Emission Tomography Computed Tomography, Prostatic Neoplasms diagnostic imaging, Radiopharmaceuticals
- Abstract
Purpose: To determine the detection rate of PET/CT in biochemical relapse of prostate cancer using [
68 Ga]PSMA I&T and to compare it with published detection rates of [68 Ga]PSMA HBED-CC., Methods: We performed a retrospective analysis in 83 consecutive patients with documented biochemical relapse after prostatectomy. All patients underwent whole body [68 Ga]PSMA I&T PET/CT. PET/CT images were evaluated for presence of local recurrence, lymph node metastases, and distant metastases. Proportions of positive PET/CT results were calculated for six subgroups with increasing prostate specific antigen (PSA) levels (<0.5 ng/mL, 0.5 to <1.0 ng/mL, 1.0 to <2.0 ng/mL, 2.0 to <5.0 ng/mL, 5.0 to <10.0, ≥10.0 ng/mL). Detection rates of [68 Ga]PSMA I&T were statistically compared with published detection rates of [68 Ga]PSMA HBED-CC using exact Fisher's test., Results: Median PSA was 0.81 (range: 0.01 - 128) ng/mL. In 58/83 patients (70 %) at least one [68 Ga]PSMA I&T positive lesion was detected. Local recurrent cancer was present in 18 patients (22 %), lymph node metastases in 29 patients (35 %), and distant metastases in 15 patients (18 %). The tumor detection rate was positively correlated with PSA levels, resulting in detection rates of 52 % (<0.5 ng/mL), 55 % (0.5 to <1.0 ng/mL), 70 % (1.0 to <2.0 ng/mL), 93 % (2.0 to <5.0 ng/mL), 100 % (5.0 to <10.0 ng/mL), and 100 % (≥10.0 ng/mL). There was no significant difference between the detection rate of [68 Ga]PSMA I&T and published detection rates of [68 Ga]PSMA HBED-CC (all p>0.05)., Conclusions: [68 Ga]PSMA I&T PET/CT has high detection rates of recurrent prostate cancer that are comparable to [68 Ga]PSMA HBED-CC.- Published
- 2017
- Full Text
- View/download PDF
3. Determination of vitamin B12 in infant formula and adult nutritionals using HPLC after purification on an immunoaffinity column: first action 2011.09.
- Author
-
Kirchner U, Degenhardt K, Raffler G, and Nelson M
- Subjects
- Adult, Algorithms, Chromatography, Liquid methods, Equipment Design, Humans, Infant, Newborn, Nutritional Sciences, Reference Values, Reproducibility of Results, Ultraviolet Rays, Chemistry Techniques, Analytical methods, Chromatography, Affinity methods, Chromatography, High Pressure Liquid methods, Dietary Supplements, Infant Formula, Vitamin B 12 analysis
- Abstract
During the "Standards Development and International Harmonization: AOAC INTERNATIONAL Mid-Year Meeting," on June 29, 2011, the method "Determination of vitamin B12 in infant formula and adult nutritionals using HPLC after purification on an immunoaffinity column" was recommended by an Expert Review Panel and adopted as AOAC Official First Action status. The method is applicable for the determination of vitamin B12 in milk-based infant formula. Vitamin B12 is extracted from the sample in sodium acetate buffer in the presence of potassium cyanide. After purification and concentration with an immunoaffinity column (IAC), vitamin B12 is determined by LC with UV detection (361 nm). Data supplied by CLF demonstrated linear response over a wide range of concentrations (1.4-39 microg/100 mL). The analytical range is 0.2-10 microg/100 g, depending on the capacity of the IACs (0.01-0.5 microg), the input weight, and dilutions. Recovery rates were assessed using National Institute of Standards and Technology SRM 1849, and determined to be 95.1%, with SD of 0.34 and CV of 9.0. Measurement uncertainty (UE) was 0.8 microg/100 g, which was calculated from the validation data. It is an expanded measurement uncertainty and was obtained through multiplication with a coverage factor k. LOQ values were reported as 0.10 microg/100 g. The performance characteristics of the method met the standard method performance requirements set forth by the AOAC Stakeholder Panel on Infant Formula and Adult Nutritionals; thus, the method was determined to be appropriate for First Action status.
- Published
- 2012
- Full Text
- View/download PDF
4. Directed evolution of an esterase from Pseudomonas fluorescens yields a mutant with excellent enantioselectivity and activity for the kinetic resolution of a chiral building block.
- Author
-
Schmidt M, Hasenpusch D, Kähler M, Kirchner U, Wiggenhorn K, Langel W, and Bornscheuer UT
- Subjects
- Alkynes pharmacology, Binding Sites genetics, Butanols pharmacology, Directed Molecular Evolution, Esterases drug effects, Esterases genetics, Kinetics, Models, Molecular, Molecular Conformation, Mutation, Protein Conformation, Protein Structure, Tertiary, Pseudomonas fluorescens genetics, Stereoisomerism, Structure-Activity Relationship, Substrate Specificity genetics, Time Factors, Alkynes chemistry, Butanols chemistry, Esterases chemistry, Pseudomonas fluorescens enzymology
- Abstract
A triple mutant of an esterase from Pseudomonas fluorescens (PFE) that was created by directed evolution exhibited high enantioselectivity (E=89) in a kinetic resolution and yielded the building block (S)-but-3-yn-2-ol. Surprisingly, a mutation close to the active site caused the formation of inclusion bodies, but remote mutations were found to be responsible for the high selectivity. Back mutations gave a variant (double mutant PFE Ile76Val/Val175Ala) that showed excellent selectivity (E=96) and activity (20 min for 50% conversion, which corresponds to 1.25 U per mg of protein).
- Published
- 2006
- Full Text
- View/download PDF
5. Nucleation particles in diesel exhaust: composition inferred from in situ mass spectrometric analysis.
- Author
-
Schneider J, Hock N, Weimer S, Borrmann S, Kirchner U, Vogt R, and Scheer V
- Subjects
- Carbon analysis, Environmental Monitoring methods, Mass Spectrometry, Particle Size, Air Pollutants analysis, Vehicle Emissions analysis
- Abstract
Mass spectrometric measurements of size and composition of diesel exhaust particles have been performed under various conditions: chassis dynamometer tests, field measurements near a German motorway, and individual car chasing. Nucleation particles consisting of volatile sulfate and organic material could be detected both at the chassis dynamometer test facility and during individual car chasing. We found evidence that if nucleation occurs, sulfuric acid/water is the nucleating agent. Low-volatile organics species condense only on the preexisting sulfuric acid/water clusters. Nucleation was found to depend strongly on various parameters such as exhaust dilution conditions, fuel sulfur content, and engine load. The latter determines the fraction of the fuel sulfur that is converted to sulfuric acid. The organic compounds (volatile and low-volatile) condense only on preexisting particles, such as both sulfuric acid nucleation particles and larger accumulation mode soot particles. On the latter, sulfuric acid also condenses, if the conditions for nucleation are not given. The overall ratio of sulfate to organic (volatile and low-volatile) is also strongly dependent on the engine load. It was found that the production of nucleation particles even at high engine load can be suppressed by using low-sulfur fuel.
- Published
- 2005
- Full Text
- View/download PDF
6. Phenol hydroxylase from Bacillus thermoglucosidasius A7, a two-protein component monooxygenase with a dual role for FAD.
- Author
-
Kirchner U, Westphal AH, Müller R, and van Berkel WJ
- Subjects
- Amino Acid Sequence, Archaeoglobus fulgidus enzymology, Catalysis, Catechols chemistry, Chromatography, High Pressure Liquid, Cysteine chemistry, Dimerization, Dose-Response Relationship, Drug, Electrophoresis, Polyacrylamide Gel, Escherichia coli metabolism, Kinetics, Models, Chemical, Models, Molecular, Molecular Sequence Data, NAD metabolism, Phenol chemistry, Plasmids metabolism, Protein Binding, Recombinant Proteins metabolism, Sequence Homology, Amino Acid, Spectrophotometry, Temperature, Bacillus enzymology, Flavin-Adenine Dinucleotide chemistry, Mixed Function Oxygenases chemistry
- Abstract
A novel phenol hydroxylase (PheA) that catalyzes the first step in the degradation of phenol in Bacillus thermoglucosidasius A7 is described. The two-protein system, encoded by the pheA1 and pheA2 genes, consists of an oxygenase (PheA1) and a flavin reductase (PheA2) and is optimally active at 55 degrees C. PheA1 and PheA2 were separately expressed in recombinant Escherichia coli BL21(DE3) pLysS cells and purified to apparent homogeneity. The pheA1 gene codes for a protein of 504 amino acids with a predicted mass of 57.2 kDa. PheA1 exists as a homodimer in solution and has no enzyme activity on its own. PheA1 catalyzes the efficient ortho-hydroxylation of phenol to catechol when supplemented with PheA2 and FAD/NADH. The hydroxylase activity is strictly FAD-dependent, and neither FMN nor riboflavin can replace FAD in this reaction. The pheA2 gene codes for a protein of 161 amino acids with a predicted mass of 17.7 kDa. PheA2 is also a homodimer, with each subunit containing a highly fluorescent FAD prosthetic group. PheA2 catalyzes the NADH-dependent reduction of free flavins according to a Ping Pong Bi Bi mechanism. PheA2 is structurally related to ferric reductase, an NAD(P)H-dependent reductase from the hyperthermophilic Archaea Archaeoglobus fulgidus that catalyzes the flavin-mediated reduction of iron complexes. However, PheA2 displays no ferric reductase activity and is the first member of a newly recognized family of short-chain flavin reductases that use FAD both as a substrate and as a prosthetic group.
- Published
- 2003
- Full Text
- View/download PDF
7. Phenol/cresol degradation by the thermophilic Bacillus thermoglucosidasius A7: cloning and sequence analysis of five genes involved in the pathway.
- Author
-
Duffner FM, Kirchner U, Bauer MP, and Müller R
- Subjects
- Aldehyde Oxidoreductases genetics, Bacillus enzymology, Bacillus genetics, Biodegradation, Environmental, Catechol 2,3-Dioxygenase, Cloning, Molecular, DNA, Bacterial chemistry, DNA, Bacterial genetics, Escherichia coli genetics, Genes, Bacterial genetics, Hydro-Lyases genetics, Hydrolases genetics, Mixed Function Oxygenases genetics, Molecular Sequence Data, Open Reading Frames, Operon, Oxygenases genetics, Proteins genetics, Sequence Analysis, DNA, Bacillus metabolism, Cresols metabolism, Dioxygenases, Phenol metabolism
- Abstract
Bacillus thermoglucosidasius A7 degraded phenol at 65 degrees C via the meta cleavage pathway. Five enzymes used in the metabolism of phenol were cloned from B. thermoglucosidasius A7 into pUC18. Nine open reading frames were present on the 8.1kb insert, six of which could be assigned a function in phenol degradation using database homologies and enzyme activities. The phenol hydroxylase is a two-component enzyme encoded by pheA1 and pheA2. The larger component (50kDa) has 49% amino acid identity with the 4-hydroxyphenylacetate hydroxylase of Escherichia coli, while the smaller component (19kDa) is most related (30% amino acid identity) to the styrene monoxygenase component B from Pseudomonas fluorescens. Both components were neccessary for activity. The catechol 2, 3-dioxygenase encoded by pheB has 45% amino acid identity with dmpB of Pseudomonas sp. CF600 and could be assigned to superfamily I, family 2 and a new subfamily of the Eltis and Bolin grouping. The 2-hydroxymuconic acid semialdehyde hydrolase (2HMSH), encoded by pheC, revealed the highest amino acid identity (36%) to the equivalent enzyme from Pseudomonas sp. strain CF600, encoded by dmpD. Based on sequence identity, pheD and pheE were deduced to encode the 2-hydroxypenta-2,4-dienoate hydratase (2HDH), demonstrating 45% amino acid identity to the gene product of cumE from Pseudomonas fluorescens and the acetaldehyde dehydrogenase (acylating) demonstrating 57% amino acid identity to the gene product of bphJ from Pseudomonas LB400.
- Published
- 2000
- Full Text
- View/download PDF
8. Abstracts of the 6th FECS Conference 1998 Lectures.
- Author
-
Rowland FS, Blake DR, Larsen BR, Lindskog A, Peterson PJ, Williams WP, Wallington TJ, Pilling MJ, Carslaw N, Creasey DJ, Heard DE, Jacobs P, Lee J, Lewis AC, McQuaid JB, Stockwell WR, Frank H, Sacco P, Cocheo V, Lynge E, Andersen A, Nilsson R, Barlow L, Pukkala E, Nordlinder R, Boffetta P, Grandjean P, Heikkil P, Hürte LG, Jakobsson R, Lundberg I, Moen B, Partanen T, Riise T, Borowiak A, De Saeger E, Schnitzler KG, Gravenhorst G, Jacobi HW, Moelders S, Lammel G, Busch G, Beese FO, Dentener FJ, Feichter J, Fraedrich K, Roelofs GJ, Friedrich R, Reis S, Voehringer F, Simpson D, Moussiopoulos N, Sahm P, Tourlou PM, Salmons R, Papameletiou D, Maqueda JM, Suhr PB, Bell W, Paton-Walsh C, Woods PT, Partridge RH, Slemr J, Slemr F, Schmidbauer N, Ravishankara AR, Jenkin ME, de Leeuw G, van Eijk AM, Flossmann AI, Wobrock W, Mestayer PG, Tranchant B, Ljungström E, Karlsson R, Larsen SE, Roemer M, Builtjes PJ, Koffi B, Koffi EN, De Saeger E, Ro-Poulsen H, Mikkelsen TN, Hummelshøj P, Hovmand MF, Simoneit BR, van der Meulen A, Meyer MB, Berndt T, Böge O, Stratmann F, Cass GR, Harrison RM, Shi JP, Hoffmann T, Warscheid B, Bandur R, Marggraf U, Nigge W, Kamens R, Jang M, Strommen M, Chien CJ, Leach K, Ammann M, Kalberer M, Arens F, Lavanchy V, Gâggeler HW, Baltensperger U, Davies JA, Cox RA, Alonso SG, Pastor RP, Argüello GA, Willner H, Berndt T, Böge O, Bogillo VI, Pokrovskiy VA, Kuraev OV, Gozhyk PF, Bolzacchini E, Bruschi M, Fantucci P, Meinardi S, Orlandi M, Rindone B, Bolzacchini E, Bohn B, Rindone B, Bruschi M, Zetzsch C, Brussol C, Duane M, Larsen B, Carlier P, Kotzias D, Caracena AB, Aznar AM, Ferradás EG, Christensen CS, Skov H, Hummelshøj P, Jensen NO, Lohse C, Cocheo V, Sacco P, Chatzis C, Cocheo V, Sacco P, Boaretto C, Quaglio F, Zaratin L, Pagani D, Cocheo L, Cocheo V, Asnar AM, Baldan A, Ballesta PP, Boaretto C, Caracena AB, Ferradas EG, Gonzalez-Flesca N, Goelen E, Hansen AB, Sacco P, De Saeger E, Skov H, Consonni V, Gramatica P, Santagostino A, Galvani P, Bolzacchini E, Consonni V, Gramatica P, Todeschini R, Dippel G, Reinhardt H, Zellner R, Dämmer K, Bednarek G, Breil M, Zellner R, Febo A, Allegrini I, Giliberti C, Perrino C, Fogg PG, Geiger H, Barnes I, Becker KH, Maurer T, Geyskens F, Bormans R, Lambrechts M, Goelen E, Giese M, Frank H, Glasius M, Hornung P, Jacobsen JK, Klausen HS, Klitgaard KC, Møller CK, Petersen AP, Petersen LS, Wessel S, Hansen TS, Lohse C, Boaretto E, Heinemeier J, Glasius M, Di Bella D, Lahaniati M, Calogirou A, Jensen NR, Hjorth J, Kotzias D, Larsen BR, Gonzalez-Flesca N, Cicolella A, Bates M, Bastin E, Gurbanov MA, Akhmedly KM, Balayev VS, Haselmann KF, Ketola R, Laturnus F, Lauritsen FR, Grøn C, Herrmann H, Ervens B, Reese A, Umschlag T, Wicktor F, Zellner R, Herrmann H, Umschlag T, Müller K, Bolzacchini E, Meinardi S, Rindone B, Jenkin ME, Hayman GD, Jensen NO, Courtney M, Hummelshøj P, Christensen CS, Larsen BR, Johnson MS, Hegelund F, Nelander B, Kirchner F, Klotz B, Barnes I, Sørensen S, Becker KH, Etzkorn T, Platt U, Wirtz K, Martín-Reviejo M, Laturnus F, Martinez E, Cabañas B, Aranda A, Martín P, Salgado S, Rodriguez D, Masclet P, Jaffrezo JL, Hillamo R, Mellouki A, Le Calvé S, Le Bras G, Moriarty J, O'Donnell S, Wenger J, Sidebottom H, Mingarrol MT, Cosin S, Pastor RP, Alonso SG, Sanz MJ, Bravo I, Gonzalez D, Pérez MA, Mustafaev I, Mammadova S, Noda J, Hallquist M, Langer S, Ljungström E, Nohara K, Kutsuna S, Ibusuki T, Oehme M, Kölliker S, Brombacher S, Merz L, Pastor RP, Alonso SG, Cabezas AQ, Peeters J, Vereecken L, El Yazal J, Pfeffer HU, Breuer L, Platz J, Nielsen OJ, Sehested J, Wallington TJ, Ball JC, Hurley MD, Straccia AM, Schneider WF, Pérez-Casany MP, Nebot-Gil I, Sánchez-Marín J, Putz E, Folberth G, Pfister G, Weissflog L, Elansky NP, Sørensen S, Barnes I, Becker KH, Shao M, Heiden AC, Kley D, Rockel P, Wildt J, Silva GV, Vasconcelos MT, Fernandes EO, Santos AM, Skov H, Hansen A, Løfstrøm P, Lorenzen G, Stabel JR, Wolkoff P, Pedersen T, Strom AB, Skov H, Hertel O, Jensen FP, Hjorth J, Galle B, Wallin S, Theloke J, Libuda HG, Zabel F, Touaty M, Bonsang B, Ullerstam M, Langer S, Ljungström E, Wenger J, Bonard A, Manning M, Nolan S, O'Sullivan N, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Collins E, Moriarty J, O'Donnell S, Sidebottom H, Wenger J, Sidebottom H, Chadwick P, O'Leary B, Treacy J, Wolkoff P, Clausen PA, Wilkins CK, Hougaard KS, Nielsen GD, Zilinskis V, Jansons G, Peksens A, Lazdins A, Arinci YV, Erdöl N, Ekinci E, Okutan H, Manlafalioglu I, Bakeas EB, Siskos PA, Viras LG, Smirnioudi VN, Bottenheim JW, Biesenthal T, Gong W, Makar P, Delmas V, Menard T, Tatry V, Moussafir J, Thomas D, Coppalle A, Ellermann T, Hertel O, Skov H, Frohn L, Manscher OH, Friis J, Girgzdiene R, Girgzdys A, Gurevich NA, Gårdfeldt K, Langer S, Hermans C, Vandaele AC, Carleer M, Fally S, Colin R, Bernath PF, Jenouvrier A, Coquart B, Mérienne MF, Hertel O, Frohn L, Skov H, Ellermann T, Huntrieser H, Schlager H, Feigl C, Kemp K, Palmgren F, Kiilsholm S, Rasmussen A, Sørensen JH, Klemm O, Lange H, Larsen RW, Larsen NW, Nicolaisen F, Sørensen GO, Beukes JA, Larsen PB, Jensen SS, Fenger J, de Leeuw G, Kunz G, Cohen L, Schlünzen H, Muller F, Schulz M, Tamm S, Geernaert G, Hertel O, Pedersen B, Geernaert LL, Lund S, Vignati E, Jickells T, Spokes L, Matei C, Jinga OA, Jinga DC, Moliner R, Braekman-Danheux C, Fontana A, Suelves I, Thieman T, Vassilev S, Skov H, Hertel O, Zlatev Z, Brandt J, Bastrup-Birk A, Ellermann T, Frohn L, Vandaele AC, Hermans C, Carleer M, Tsouli A, Colin R, Windsperger AM, Turi K, Dworak O, Zellweger C, Weingartner E, Rüttimann R, Hofer P, Baltensperger U, Ziv A, Iakovleva E, Palmgren F, Berkovicz R, Skov H, Alastuey A, Querol X, Chaves A, Lopez-Soler A, Ruiz C, Andrees JM, Allegrini I, Febo A, Giusto M, Angeloni M, Di Filippo P, D'Innocenzio F, Lepore L, Marconi A, Arshinov MY, Belan BD, Davydov DK, Kovaleskii VK, Plotinov AP, Pokrovskii EV, Sklyadneva TK, Tolmachev GN, Arshinov MY, Belan BD, Sklyadneva TK, Behnke W, Elend M, Krüger U, Zetzsch C, Belan BD, Arshinov MY, Davydov DK, Kovalevskii VK, Plotnikov AP, Pokrovskii EV, Rasskazchikova TM, Sklyadneva TK, Tolmachev GN, Belan BD, Arshinov MY, Simonenkov DV, Tolmachev GN, Bilde M, Aker PM, Börensen C, Kirchner U, Scheer V, Vogt R, Ellermann T, Geernaert LL, Pryor SC, Barthelmie RJ, Feilberg A, Nielsen T, Kamens RM, Freitas MC, Marques AP, Reis MA, Alves LC, Ilyinskikh NN, Ilyinskikh IN, Ilyinskikh EN, Johansen K, Stavnsbjerg P, Gabrielsson P, Bak F, Andersen E, Autrup H, Kamens R, Jang M, Strommen M, Leach K, Kirchner U, Scheer V, Börensen C, Vogt R, Igor K, Svjatoslav G, Anatoliy B, Komov IL, Istchenko AA, Lourenço MG, Mactavish D, Sirois A, Masclet P, Jaffrezo JL, van der Meulen A, Milukaite A, Morkunas V, Jurgutis P, Mikelinskiene A, Nielsen T, Feilberg A, Binderup ML, Pineda M, Palacios JM, Garcia E, Cilleruelo C, Moliner R, Popovitcheva OB, Trukhin ME, Persiantseva NM, Buriko Y, Starik AM, Demirdjian B, Suzanne J, Probst TU, Rietz B, Alfassi ZB, Pokrovskiy VA, Zenobi R, Bogatyr'ov VM, Gun'ko VM, Querol X, Alastuey A, Lopez-Soler A, Mantilla E, Plana F, Artiño B, Rauterberg-Wulff A, Israël GW, Rocha TA, Duarte AC, Röhrl A, Lammel G, Spindler G, Müller K, Herrmann H, Strommen MR, Vignati E, de Leeuw G, and Berkowicz R
- Published
- 1998
- Full Text
- View/download PDF
9. Heart rate variability in time and frequency domains: effects of gallopamil, nifedipine, and metoprolol compared with placebo.
- Author
-
Schweizer MW, Brachmann J, Kirchner U, Walter-Sack I, Dickhaus H, Metze C, and Kübler W
- Subjects
- Adult, Humans, Male, Single-Blind Method, Sympathetic Nervous System drug effects, Blood Pressure drug effects, Gallopamil pharmacology, Heart Rate drug effects, Metoprolol pharmacology, Nifedipine pharmacology
- Abstract
Objective: To assess the effects of three different antianginal drugs on heart rate, blood pressure, and heart rate variability., Design: Randomised, single blind, placebo controlled, cross over study., Setting: University hospital., Participants: Nine healthy male volunteers., Interventions: Oral administration of either 50 mg gallopamil, 20 mg nifedipine, 100 mg metoprolol, or placebo according to a random crossover plan., Main Outcome Measures: Time intervals between consecutive R waves in electrocardiograms measured with an accuracy of 5 ms from digital Holter recordings. Blood pressure monitored continuously by finger plethysmography., Results: Metoprolol lowered heart rate from 62(6) to 51(5) beats/min (p = 0.003) after 78(23) minutes. Nifedipine provoked reflex tachycardia from 56(5) to 94(18) beats/min (p < 0.001) at 10(3) minutes after treatment followed by an exponential decline in heart rate to baseline values with a time constant of 34(7) min in seven subjects but 83 minutes in one volunteer. One subject showed no exponential decline in heart rate. Nifedipine significantly lowered the supine mean arterial pressure from 86(6) to 67(6) mm Hg (p = 0.004) after 11(2) minutes, indicating an acute reduction in arterial resistance. Gallopamil did not significantly change mean heart rate or blood pressure. In the sitting position three hours after administration gallopamil and metoprolol significantly lowered power spectral density in the low frequency band (0.03 Hz to 0.15 Hz) compared with placebo (p < 0.05). Nifedipine did not produce such an effect., Conclusions: Gallopamil and metoprolol both inhibit cardiac sympathetic activation compared with placebo, whereas nifedipine causes reflex sympathetic activation.
- Published
- 1993
- Full Text
- View/download PDF
10. [Micromorphologic and mineralogic observations of the structure of tooth enamel].
- Author
-
Kirchner UL and Busch W
- Subjects
- Apatites metabolism, Crystallography, Dental Caries pathology, Humans, Microscopy, Electron, Minerals metabolism, Dental Enamel ultrastructure
- Published
- 1983
11. [Microprobe study to determine the degree of mineralization of the pre- and postnatally formed enamel components of human milk teeth].
- Author
-
Kirchner U, Lenz H, and Newesely H
- Subjects
- Berlin, Brazil, Calcium analysis, Child, Humans, Microscopy, Electron methods, Phosphorus analysis, X-Ray Diffraction methods, Amelogenesis, Dental Enamel growth & development, Tooth Calcification, Tooth, Deciduous growth & development
- Published
- 1979
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.